infantile hepatitis syndrome
Conditions
Interventions
experimental group:rich-MCFAs diet
control group:Ordinary formula
Sponsors
Guangdong Maternal and Child Health Association
Eligibility
Sex/Gender
All
Age
No minimum to 1 Years
Inclusion criteria
Inclusion criteria: 1. Children were diagnosed as cholestatic infant hepatitis syndrome in the Department of Gastroenterology, Children's Hospital, Chongqing Medical University,from September 2019 to September 2020. 2. The guardian voluntarily agreed to join the study.
Exclusion criteria
Exclusion criteria: Excluding the following causes of cholestatic IHS: intrahepatic and extrahepatic bile duct and liver interstitial dysplasia (including intrahepatic bile duct deficiencies, neonatal sclerosing cholangitis, extrahepatic biliary atresia, choledochal cyst, biliary tract syndrome, etc.); Others such as blood system diseases, poisoning or long-term use of parenteral nutrition caused by jaundice.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Liver signs;Alanine aminotransferase;Bilirubin;bile acid;Alkaline phosphatase;?-Glutamyl transferase;albumin; | — |
Secondary
| Measure | Time frame |
|---|---|
| weight;Gastrointestinal symptoms;blood routine;Urine routine;fecal routine; | — |
Countries
China
Contacts
Public ContactLiu Bo
Department of Gastroenterology, Children's Hospital, Chongqing Medical University
Outcome results
None listed